GRCE

3.11

1.43% -0.045

Vorhandelsmarkt: 3.10 -0.010 -0.32%

Grace Therapeutics Inc (GRCE)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$3.155

Offen:

$3.11

24-Stunden-Volumen:

17,976

Relative Volume:

0.22

Marktkapitalisierung:

$43.01M

Einnahmen:

Nettoeinkommen (Verlust:

$-10.31M

KGV:

-4.039

EPS:

-0.77

Netto-Cashflow:

$-12.65M

1W Leistung:

-1.27%

1M Leistung:

+2.81%

6M Leistung:

+2.47%

1J Leistung:

+0.32%

1-Tages-Spanne:

$3.10

$3.155

1-Wochen-Bereich:

$3.10

$3.25

52-Wochen-Spanne:

$1.75

$4.965

Grace Therapeutics Inc Stock (GRCE) Company Profile

Firmenname

Grace Therapeutics Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

609-322-1602

Adresse

103 CARNEGIE CENTER, PRINCETON

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GRCE's Discussions on Twitter

Vergleichen Sie GRCE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GRCE Grace Therapeutics Inc	3.11	47.87M	0	-10.31M	-12.65M	-0.77
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-02	Eingeleitet	TD Cowen	Buy
2020-09-01	Herabstufung	Oppenheimer	Outperform → Perform
2020-07-06	Hochstufung	B. Riley FBR	Neutral → Buy
2020-01-13	Herabstufung	B. Riley FBR	Buy → Neutral
2019-08-29	Eingeleitet	B. Riley FBR	Buy
2019-07-18	Eingeleitet	Oppenheimer	Outperform
2019-06-26	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Grace Therapeutics Inc Aktie (GRCE) Neueste Nachrichten

04:16 AM

Why Grace Therapeutics Inc. stock could rally in 2025Weekly Risk Report & Weekly Top Gainers Trade List - newser.com

04:16 AM

03:49 AM

Published on: 2025-11-04 02:49:13 - newser.com

03:49 AM

Nov 03, 2025

Why Grace Therapeutics Inc. stock remains on watchlistsJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com

Nov 03, 2025

Grace Therapeutics Inc. stock outlook for YEAR2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com

Nov 03, 2025

Using RSI to spot recovery in Grace Therapeutics Inc.Market Sentiment Review & Safe Capital Preservation Plans - newser.com

Nov 03, 2025

Can Grace Therapeutics Inc. stock rebound after recent weaknessWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 03, 2025

Will Grace Therapeutics Inc. stock outperform Nasdaq indexMarket Trend Review & Low Drawdown Trading Techniques - newser.com

Nov 03, 2025

Is Grace Therapeutics Inc. forming a bottoming basePortfolio Return Report & AI Powered Market Entry Ideas - newser.com

Nov 03, 2025

Will Grace Therapeutics Inc. stock outperform value stocksQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025

Can Grace Therapeutics Inc. stock resist market sell offsInsider Selling & Reliable Breakout Forecasts - newser.com

Nov 03, 2025

Is Grace Therapeutics Inc. stock a safe haven assetJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Building trade automation scripts for Grace Therapeutics Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com

Nov 02, 2025

Is this a good reentry point in Grace Therapeutics Inc.Gap Up & Low Risk Entry Point Guides - newser.com

Nov 02, 2025

Published on: 2025-11-02 05:34:07 - newser.com

Nov 02, 2025

Is Grace Therapeutics Inc. stock attractive for growth ETFsProfit Target & AI Based Trade Execution Alerts - newser.com

Nov 02, 2025